These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2205987)

  • 1. [The development of immunoscintigraphy into a routine method].
    Pateisky N
    Wien Klin Wochenschr; 1990 Aug; 102(15):424-6. PubMed ID: 2205987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of immunoscintigraphy using monoclonal antibodies on the analysis of hormones and tumor markers. This is not the end of it!].
    Verheijen RH; Schijf CP
    Ned Tijdschr Geneeskd; 1989 Sep; 133(35):1760. PubMed ID: 2797292
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor markers as targets for selective diagnostic and therapeutic procedures.
    Roselli M; Guadagni F; Buonomo O; Belardi A; Ferroni P; Diodati A; Anselmi D; Cipriani C; Casciani CU; Greiner J; Schlom J
    Anticancer Res; 1996; 16(4B):2187-92. PubMed ID: 8694541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antigenic markers in the cytological diagnosis of human malignant neoplasms].
    Frank GA; Pugachev KK; Shabalova IP; Shimbireva IB
    Arkh Patol; 1990; 52(8):70-4. PubMed ID: 2281989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies in the diagnosis and therapy of malignant tumors: current status amd future perspectives].
    Obrist R
    Ther Umsch; 1988 Jun; 45(6):364-9. PubMed ID: 3413710
    [No Abstract]   [Full Text] [Related]  

  • 6. New approaches in gastric cancer research: I. Monoclonal antibodies in diagnosis and therapy.
    Juhl H
    Hepatogastroenterology; 1989 Feb; 36(1):27-32. PubMed ID: 2663689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symposium on diagnosis and treatment of cancer. Recent progress.
    Jpn J Med; 1988 Feb; 27(1):96-112. PubMed ID: 2452911
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of markers in the histological diagnosis of tumors].
    Le Doussal V
    Pathol Biol (Paris); 1993 Jan; 41(1):33-4. PubMed ID: 8316460
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serodiagnosis: tumor marker].
    Yoneshima M; Hattori N; Sawabu N
    Gan No Rinsho; 1988 Aug; 34(10):1209-15. PubMed ID: 2459425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of access ultrasensitive human growth hormone assay to monoclonal antibody-based immunoradiometric assay.
    Iwahara K; Tanabe C; Maekawa M
    Clin Chim Acta; 2007 Feb; 376(1-2):248-9. PubMed ID: 17126825
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tumor marker analyses--valuable tools if used correctly].
    Børmer OP; Paus E; Nustad K; Theodorsen L
    Tidsskr Nor Laegeforen; 1994 Nov; 114(28):3317-20. PubMed ID: 7809890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in the use of monoclonal antibodies for imaging and therapy.
    Monson JR
    Curr Opin Gen Surg; 1993; ():334-9. PubMed ID: 7584004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
    Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
    Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum tissue polypeptide antigen (TPA): monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer.
    Bennink R; Van Poppel H; Billen J; Decoster M; Baert L; Mortelmans L; Blanckaert N
    Anticancer Res; 1999; 19(4A):2609-13. PubMed ID: 10470203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International symposium on immunoscintigraphy: pre-congress symposium of the European Nuclear Medicine Congress 1984. Saariselka, Lapland, 10-12 August, 1984. Abstracts.
    Nucl Med Commun; 1984 Aug; 5(8):529-41. PubMed ID: 6533501
    [No Abstract]   [Full Text] [Related]  

  • 16. [Basic and clinical aspects of tumor markers--with special reference to CEA].
    Matsuoka Y
    Rinsho Byori; 1990 Jan; 38(1):31-4. PubMed ID: 2308221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
    Bray KR; Koda JE; Gaur PK
    Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies.
    Rossi S; Laurino L; Furlanetto A; Chinellato S; Orvieto E; Canal F; Facchetti F; Dei Tos AP
    Am J Clin Pathol; 2005 Aug; 124(2):295-302. PubMed ID: 16040303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An immunoradiometric assay of the serum TPA from patients with primary lung cancer and a comparison with the conventional double antibody method].
    Suzuki K; Reshad K; Akiyama J; Itoi K; Hirata T; Muro K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jun; 27(6):703-11. PubMed ID: 2552212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for 2----6 sialyl Lewis a antigen--2. Evaluation of clinical significance].
    Imura H; Takahashi T; Matsuda T; Yoshida O; Ohkura H; Seitetsu Y; Seino Y; Ishii M; Kuwabara M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2203-12. PubMed ID: 2660749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.